CytoDyn Inc. (CYDY) to Acquire Biotech Developing Therapies to Stop Cancer from Spreading
CytoDyn signs definitive agreement to acquire privately held ProstaGene Gets access to CCR5 technologies related to cancer Lead candidate PRO…
CytoDyn signs definitive agreement to acquire privately held ProstaGene Gets access to CCR5 technologies related to cancer Lead candidate PRO…
Cannabis Strategic Ventures, Inc. (OTC: NUGS) this morning announced the completion of a full audit for its fiscal year ended…
The new HUB880 Explorer ultra-high pressure based system will be used by research laboratories worldwide in food-borne pathogen research to…
Petroteq Energy (TSX.V: PQE) (OTC: PQEFF), a fully integrated oil and gas company, this morning announced the commencement of commercial…
Search engine features focused on cannabis commerce “Business media” platform that makes networking easier One-stop shop for both consumers and…
A syndicate of underwriters is to purchase 3.8 million units at C$5.27 per unit Sale terms are an amendment of…
VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced that it has qualified to trade on the OTCQX® Best…
First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF), a vertically integrated North American pure-play cobalt company, this morning announced its appointment…
British Columbia-based fully-integrated cannabis company Choom Holdings (CSE: CHOO) (OTCQB: CHOOF) this morning announced that it has entered into an…
BriaCell Therapeutics (TSX.V: BCT) (OTCQB: BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, today announced that…